Mucosal Immunology Studies Team (MIST)
The Mucosal Immunology Studies Team (MIST) is made up of the grant recipients of the NIAID’s Immune Defense Mechanisms at the Mucosa Cooperative Study Group (RFA-AI-10-008). The team’s focus is on immune defense mechanisms and immune regulation at mucosal surfaces including respiratory, gastrointestinal and urogenital tract mucosa.
The purpose of this program is to discover and define novel basic immune mechanisms, cells, mediators, and pathways that provide a more sophisticated understanding of mucosal immune defense mechanisms; to explore innovative hypotheses; and to address difficult unsolved questions in mucosal immunity. The ultimate goal is to develop the knowledge base needed to facilitate future development of vaccines and immunotherapies to protect mucosal surfaces from infection and immune-mediated pathology.
For more information please visit MIST
TB Research Unit
TB Research Unit Based at Case Western University, the TBRU works internationally to identify new approaches to prevention, diagnosis,TBRU is supported by NIH/NIAID contract HHSN266200700022C/N01-AI-70022
For more information please visit TBRU
The KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) is a truly novel initiative in global health. It began as a groundbreaking collaboration between the Howard Hughes Medical Institute (HHMI) and the University of KwaZulu-Natal (UKZN), with public sector support through LifeLabs, the biotechnology investment arm of the South African government.
K-RITH's mission is to conduct outstanding basic science research on tuberculosis (TB) and HIV and translate the scientific findings into new tools to control TB and HIV. In addition to its research mission, K-RITH is committed to motivating young scientists to address the crises of TB and HIV by expanding the science education opportunities in the region as well as strengthening the TB and HIV research capabilities of scientists throughout Africa.
For more information please visit K-RITH